EssilorLuxottica secures FDA approval for its Stellest lens
Backed by seven years of clinical research, the platform offers a comprehensive strategy to delay onset, slow progression, and improve long-term vision health for children.
See the latest news and media coverage for EssilorLuxottica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global integrated eyewear and vision care group
essilorluxottica.comLast updated
In short: EssilorLuxottica reported record H1 sales and reaffirmed leadership stability amid family disputes and expanding Meta partnerships.
Backed by seven years of clinical research, the platform offers a comprehensive strategy to delay onset, slow progression, and improve long-term vision health for children.
Adjusted operating profit increased 15% at constant currency, and the company started a partnership with Applied Materials.
The collaboration supports the Blue Forest project, a major marine reforestation initiative in the Mediterranean, absorbing CO2 and protecting biodiversity.
The companies aim to accelerate the next evolution of smart glasses, building on their successful category creation.
EssilorLuxottica stock closed at EUR 262.60 on Euronext Paris on September 12, 2026, 11.9 percent below its 52-week high. The group has announced the acquisition...
EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy. Paris, France (9 September 2026) – With reference to recent pres ...
Shares of the French luxury company EssilorLuxottica reached their highs at the end of 2025, and have fallen 40% already in what...
On this subject, see What is going on with EssilorLuxottica's governance?, published this morning in our columns, and the dispatch Leonardo Maria Del Vecchio argues...
Track EssilorLuxottica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to EssilorLuxottica and other trending companies.